Phase 3 Cholangitis Clinical Trials
13 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–13 of 13 trials
Recruiting
Phase 3
A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis
Primary Sclerosing Cholangitis
Ipsen350 enrolled1 locationNCT07387549
Recruiting
Phase 3
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Primary Biliary Cholangitis (PBC)
Ipsen276 enrolled180 locationsNCT06016842
Recruiting
Phase 3
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Primary Biliary Cholangitis
Gilead Sciences318 enrolled196 locationsNCT06051617
Recruiting
Phase 3
Open-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis
Primary Biliary Cholangitis
Zydus Therapeutics Inc.150 enrolled28 locationsNCT06427395
Recruiting
Phase 2Phase 3
Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis
Primary Biliary Cholangitis
Xijing Hospital of Digestive Diseases104 enrolled12 locationsNCT05749822
Recruiting
Phase 3
Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study
Primary Biliary Cholangitis (PBC)
Xijing Hospital of Digestive Diseases150 enrolled1 locationNCT06755541
Recruiting
Phase 3
Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis
Primary Biliary Cholangitis
Xijing Hospital of Digestive Diseases150 enrolled7 locationsNCT05751967
Recruiting
Phase 3
Fenofibrate in Primary Biliary Cholangitis: a Real World Study
Primary Biliary Cholangitis (PBC)
Xijing Hospital of Digestive Diseases300 enrolled1 locationNCT06755151
Recruiting
Phase 3
A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA
Primary Biliary Cholangitis
Cascade Pharmaceuticals, Inc135 enrolled41 locationsNCT07282353
Recruiting
Phase 3
FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy
Primary Biliary Cholangitis (PBC)
Xijing Hospital of Digestive Diseases132 enrolled1 locationNCT07296458
Recruiting
Phase 2Phase 3
Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)
Primary Biliary Cholangitis
Xijing Hospital of Digestive Diseases117 enrolled1 locationNCT06365424
Not Yet Recruiting
Phase 2Phase 3
Oral vancomycin for treating atypical gut inflammation in children
Primary sclerosing cholangitis - ulcerative colitisAtypical ulcerative colitis
Queensland Children's Hospital63 enrolled1 locationACTRN12624001372572
Active
Phase 3
Targeting the gut microbiome as a treatment for Primary Sclerosing Cholangitis: The Queensland Clinical Network Study
Primary Sclerosing Cholangitis
Princess Alexandra Hospital50 enrolled7 locationsACTRN12621000792820